12-YEAR OUTCOMES FOLLOWING PERMANENT PROSTATE BRACHYTHERAPY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER

Louis Potters; C. Morgenstern; Emil Calugaru; Paul Fearn; Anup Jassal; Joseph Presser; E.E. Mullen

doi:10.1097/01.ju.0000154633.73092.8e

ScienceGate Book Chapters

JOURNAL ARTICLE

12-YEAR OUTCOMES FOLLOWING PERMANENT PROSTATE BRACHYTHERAPY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER

Louis Potters C. Morgenstern Emil Calugaru Paul Fearn Anup Jassal Joseph Presser E.E. Mullen

Year: 2005 Journal: The Journal of Urology Vol: 173 (5)Pages: 1562-1566 Publisher: Lippincott Williams & Wilkins

DOI: 10.1097/01.ju.0000154633.73092.8e

Get Full-Text PDF Get Analytical Report

Abstract

PPB offers acceptable 12-year BFR in patients who present with clinically localized prostate cancer. Implant dosimetry continues as an important predictor for BFR, while the addition of adjuvant therapies such as hormones and external radiation are insignificant. In patients who experience biochemical failure it appears that PSA doubling time is an important predictor of survival.

Keywords:

Medicine Prostate cancer Urology Brachytherapy Proportional hazards model Prostate Prostate-specific antigen Radiation therapy Internal medicine Hormonal therapy Multivariate analysis Biochemical recurrence Stage (stratigraphy) Prostatectomy Cancer Oncology

Metrics

281

Cited By

21.29

FWCI (Field Weighted Citation Impact)

Refs

1.00

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Prostate Cancer Diagnosis and Treatment

Health Sciences → Medicine → Pulmonary and Respiratory Medicine

Prostate Cancer Treatment and Research

Health Sciences → Medicine → Pulmonary and Respiratory Medicine

Advanced Radiotherapy Techniques

Physical Sciences → Physics and Astronomy → Radiation

12-YEAR OUTCOMES FOLLOWING PERMANENT PROSTATE BRACHYTHERAPY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER

Abstract

Metrics

Citation History

Topics

Related Documents

12-Year Outcomes Following Permanent Prostate Brachytherapy in Patients with Clinically Localized Prostate Cancer

Twelve year outcomes following permanent brachytherapy in patients with clinically localized prostate cancer

Twelve year outcomes following permanent brachytherapy in patients with clinically localized prostate cancer

Distant Metastases Following Permanent Interstitial Brachytherapy for Patients With Clinically Localized Prostate Cancer

Distant Metastases following Permanent Interstitial Brachytherapy for Patients with Clinically Localized Prostate Cancer